KPIs & Operating Metrics(New)
Growth Metrics

Hologic (HOLX) EBITDA (2016 - 2025)

Historic EBITDA for Hologic (HOLX) over the last 17 years, with Q4 2025 value amounting to $263.3 million.

  • Hologic's EBITDA rose 403.0% to $263.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $747.8 million, marking a year-over-year decrease of 2023.47%. This contributed to the annual value of $823.2 million for FY2025, which is 1616.25% down from last year.
  • Latest data reveals that Hologic reported EBITDA of $263.3 million as of Q4 2025, which was up 403.0% from $236.9 million recorded in Q3 2025.
  • Over the past 5 years, Hologic's EBITDA peaked at $796.8 million during Q1 2021, and registered a low of -$7.0 million during Q1 2025.
  • In the last 5 years, Hologic's EBITDA had a median value of $253.8 million in 2024 and averaged $289.3 million.
  • As far as peak fluctuations go, Hologic's EBITDA surged by 1732857.14% in 2024, and later plummeted by 10332.7% in 2025.
  • Hologic's EBITDA (Quarter) stood at $641.3 million in 2021, then tumbled by 59.08% to $262.4 million in 2022, then fell by 24.47% to $198.2 million in 2023, then grew by 27.7% to $253.1 million in 2024, then rose by 4.03% to $263.3 million in 2025.
  • Its EBITDA stands at $263.3 million for Q4 2025, versus $236.9 million for Q3 2025 and $254.6 million for Q2 2025.